{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:36:30Z","timestamp":1790015790750,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"JSPS KAKENHI","award":["26926007"],"award-info":[{"award-number":["26926007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00520-016-3426-5","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T07:43:29Z","timestamp":1475480609000},"page":"481-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity"],"prefix":"10.1007","volume":"25","author":[{"given":"Yoshitaka","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Kasashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rio","family":"Honma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Dosaka-Akita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"3426_CR1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","volume":"17","author":"RS Go","year":"1999","unstructured":"Go RS, Adjei AA (1999) Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17:409\u2013422","journal-title":"J Clin Oncol"},{"key":"3426_CR2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994\u20131007","journal-title":"Kidney Int"},{"key":"3426_CR3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jjco\/hyu004","volume":"44","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Niho S, Toda M, Goto K, Yoh K, Umemura S et al (2014) Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study. Jpn J Clin Oncol 44:346\u2013354","journal-title":"Jpn J Clin Oncol"},{"key":"3426_CR4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(25)32105-1","volume":"213","author":"DC Dobyan","year":"1980","unstructured":"Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW (1980) Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 213:551\u2013556","journal-title":"J Pharmacol Exp Ther"},{"key":"3426_CR5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1523-1755.2003.00709.x","volume":"63","author":"K Tsuruya","year":"2003","unstructured":"Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M et al (2003) Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63:72\u201382","journal-title":"Kidney Int"},{"key":"3426_CR6","first-page":"F1181","volume":"258","author":"HR Brady","year":"1990","unstructured":"Brady HR, Kone BC, Stromski ME, Zeidel ML, Giebisch G, Gullans SR (1990) Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am J Physiol 258:F1181\u20131187","journal-title":"Am J Physiol"},{"key":"3426_CR7","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1681\/ASN.V134858","volume":"13","author":"MS Park","year":"2002","unstructured":"Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13:858\u2013865","journal-title":"J Am Soc Nephrol"},{"key":"3426_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0885066604271539","volume":"20","author":"GM Tong","year":"2005","unstructured":"Tong GM, Rude RK (2005) Magnesium deficiency in critical illness. J Intensive Care Med 20:3\u201317","journal-title":"J Intensive Care Med"},{"key":"3426_CR9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1056\/NEJM196804042781406","volume":"278","author":"WE Wacker","year":"1968","unstructured":"Wacker WE, Parisi AF (1968) Magnesium metabolism. N Engl J Med 278:772\u2013776","journal-title":"N Engl J Med"},{"key":"3426_CR10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.296.6620.455","volume":"296","author":"I D\u00f8rup","year":"1988","unstructured":"D\u00f8rup I, Skajaa K, Clausen T, Kjeldsen K (1988) Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. Br Med J (Clin Res Ed) 296:455\u2013458","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3426_CR11","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0002-8703(91)90160-J","volume":"121","author":"RA Reinhart","year":"1991","unstructured":"Reinhart RA (1991) Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. Am Heart J 121:1513\u20131521","journal-title":"Am Heart J"},{"key":"3426_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/10409237909102564","volume":"6","author":"AS Mildvan","year":"1979","unstructured":"Mildvan AS, Loeb LA (1979) The role of metal ions in the mechanisms of DNA and RNA polymerases. CRC Crit Rev Biochem 6:219\u2013244","journal-title":"CRC Crit Rev Biochem"},{"key":"3426_CR13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00520-008-0574-2","volume":"17","author":"RJ Hunter","year":"2009","unstructured":"Hunter RJ, Pace MB, Burns KA, Burke CC, Gonzales DA, Webb NF et al (2009) Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer 17:1195\u20131201","journal-title":"Support Care Cancer"},{"key":"3426_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","volume":"25","author":"H Lajer","year":"1999","unstructured":"Lajer H, Daugaard G (1999) Cisplatin and hypomagnesemia. Cancer Treat Rev 25:47\u201358","journal-title":"Cancer Treat Rev"},{"key":"3426_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/01926230490508821","volume":"32","author":"AE Vickers","year":"2004","unstructured":"Vickers AE, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P (2004) Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol 32:577\u2013590","journal-title":"Toxicol Pathol"},{"key":"3426_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/bjc.1986.147","volume":"54","author":"JC Willox","year":"1986","unstructured":"Willox JC, McAllister EJ, Sangster G, Kaye SB (1986) Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial. Br J Cancer 54:19\u201323","journal-title":"Br J Cancer"},{"key":"3426_CR17","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.ejca.2008.08.005","volume":"44","author":"L Bodnar","year":"2008","unstructured":"Bodnar L, Wcislo G, Gasowska-Bodnar A, Synowiec A, Szarlej-Wcis\u0142o K, Szczylik C (2008) Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a randomised phase II study. Eur J Cancer 44:2608\u20132614","journal-title":"Eur J Cancer"},{"key":"3426_CR18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00000421-199208000-00016","volume":"15","author":"M Martin","year":"1992","unstructured":"Martin M, Diaz-Rubio E, Casado A, L\u00f3pez Vega JM, Sastre J, Almenarez J (1992) Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trial. Am J Clin Oncol 15:348\u2013351","journal-title":"Am J Clin Oncol"},{"key":"3426_CR19","doi-asserted-by":"crossref","unstructured":"Kidera Y, Kawakami H, Sakiyama T, Okamoto K, Tanaka K, Takeda M et al (2014) Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection. PLoS One doi: 10.1371\/journal.pone.0101902","DOI":"10.1371\/journal.pone.0101902"},{"key":"3426_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1523-1755.2004.00720.x","volume":"66","author":"T Ludwig","year":"2004","unstructured":"Ludwig T, Riethm\u00fcller C, Gekle M, Schwerdt G, Oberleithner H (2004) Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int 66:196\u2013202","journal-title":"Kidney Int"},{"key":"3426_CR21","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.bcp.2010.08.019","volume":"80","author":"T Nakamura","year":"2010","unstructured":"Nakamura T, Yonezawa A, Hashimoto S, Katsura T, Inui K (2010) Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity. Biochem Pharmacol 80:1762\u20131767","journal-title":"Biochem Pharmacol"},{"key":"3426_CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bcp.2010.11.016","volume":"81","author":"A Yonezawa","year":"2011","unstructured":"Yonezawa A, Inui K (2011) Organic cation transporter OCT\/SLC22A and H(+)\/organic cation antiporter MATE\/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem Pharmacol 81:563\u2013568","journal-title":"Biochem Pharmacol"},{"key":"3426_CR23","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-07-4793","volume":"14","author":"KK Filipski","year":"2008","unstructured":"Filipski KK, Loos WJ, Verweij J, Sparreboom A (2008) Interaction of cisplatin with the human organic cation transporter 2. Clin Cancer Res 14:3875\u20133880","journal-title":"Clin Cancer Res"},{"key":"3426_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2133\/dmpk.19.239","volume":"19","author":"H Fukushima-Uesaka","year":"2004","unstructured":"Fukushima-Uesaka H, Maekawa K, Ozawa S, Komamura K, Ueno K, Shibakawa M et al (2004) Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). Drug Metab Pharmacokinet 19:239\u2013244","journal-title":"Drug Metab Pharmacokinet"},{"key":"3426_CR25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10157-012-0638-y","volume":"16","author":"K Iwata","year":"2012","unstructured":"Iwata K, Aizawa K, Kamitsu S, Jingami S, Fukunaga E, Yoshida M et al (2012) Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events. Clin Exp Nephrol 16:843\u2013851","journal-title":"Clin Exp Nephrol"},{"key":"3426_CR26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10157-009-0215-1","volume":"13","author":"K Yokoo","year":"2009","unstructured":"Yokoo K, Murakami R, Matsuzaki T, Yoshitome K, Hamada A, Saito H (2009) Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats. Clin Exp Nephrol 13:578\u2013584","journal-title":"Clin Exp Nephrol"},{"key":"3426_CR27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1039\/an9952000859","volume":"120","author":"IB Afanas\u2019ev","year":"1995","unstructured":"Afanas\u2019ev IB, Suslova TB, Cheremisina ZP, Abramova Korkina LG (1995) Study of antioxidant properties of metal aspartates. Analyst 120:859\u2013862","journal-title":"Analyst"},{"key":"3426_CR28","doi-asserted-by":"crossref","first-page":"F369","DOI":"10.1152\/ajprenal.00127.2014","volume":"307","author":"MH Solanki","year":"2014","unstructured":"Solanki MH, Chatterjee PK, Gupta M, Xue X, Plagov A, Metz MH et al (2014) Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation. Am J Physiol Renal Physiol 307:F369\u2013F384","journal-title":"Am J Physiol Renal Physiol"},{"key":"3426_CR29","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2:2490\u20132518","journal-title":"Toxins (Basel)"},{"key":"3426_CR30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1349-7006.2010.01764.x","volume":"102","author":"I Sekine","year":"2011","unstructured":"Sekine I, Kubota K, Tamura Y, Asahina H, Yamada K, Horinouchi H et al (2011) Innovator and generic cisplatin formulations: comparison of renal toxicity. Cancer Sci 102:162\u2013165","journal-title":"Cancer Sci"},{"key":"3426_CR31","first-page":"562","volume":"4","author":"K Muraki","year":"2012","unstructured":"Muraki K, Koyama R, Honma Y, Yagishita S, Shukuya T, Ohashi R et al (2012) Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer. J Thorac Dis 4:562\u2013568","journal-title":"J Thorac Dis"},{"key":"3426_CR32","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bcp.2005.09.020","volume":"70","author":"A Yonezawa","year":"2005","unstructured":"Yonezawa A, Masuda S, Nishihara K, Yano I, Katsura T, Inui K (2005) Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biochem Pharmacol 70:1823\u20131831","journal-title":"Biochem Pharmacol"},{"key":"3426_CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(00)01525-8","volume":"473","author":"Y Urakami","year":"2000","unstructured":"Urakami Y, Okuda M, Saito H, Inui K (2000) Hormonal regulation of organic cation transporter OCT2 expression in rat kidney. FEBS Lett 473:173\u2013176","journal-title":"FEBS Lett"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3426-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T22:23:28Z","timestamp":1749594208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3426-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3426"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3426-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]}}}